Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia.

Kobbernagel HE, Buchvald FF, Haarman EG, Casaulta C, Collins SA, Hogg C, Kuehni CE, Lucas JS, Omran H, Quittner AL, Werner C, Nielsen KG.

BMC Pulm Med. 2016 Jul 22;16(1):104. doi: 10.1186/s12890-016-0261-x.

2.

Immunomodulatory effect of macrolides: At what cost?

Kipourou M, Manika K, Papavasileiou A, Pitsiou G, Lada M, Ntinapogias E, Kioumis I.

Respir Med Case Rep. 2016 Jan 15;17:44-6. doi: 10.1016/j.rmcr.2016.01.004. eCollection 2016.

3.

Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study.

Dury S, Colosio C, Etienne I, Anglicheau D, Merieau E, Caillard S, Rivalan J, Thervet E, Essig M, Babinet F, Subra JF, Toubas O, Rieu P, Launois C, Perotin-Collard JM, Lebargy F, Deslée G; Spiesser group.

BMC Pulm Med. 2015 Nov 7;15:141. doi: 10.1186/s12890-015-0133-9.

4.

Drug-Related Pneumonitis During Mammalian Target of Rapamycin Inhibitor Therapy: Radiographic Pattern-Based Approach in Waldenström Macroglobulinemia as a Paradigm.

Nishino M, Boswell EN, Hatabu H, Ghobrial IM, Ramaiya NH.

Oncologist. 2015 Sep;20(9):1077-83. doi: 10.1634/theoncologist.2015-0033. Epub 2015 Jul 23.

5.

Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.

Koh WJ, Jeong BH, Jeon K, Park HY, Kim SY, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL.

Antimicrob Agents Chemother. 2015 Aug;59(8):4994-6. doi: 10.1128/AAC.00648-15. Epub 2015 May 18.

6.

Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials.

Fan LC, Lu HW, Wei P, Ji XB, Liang S, Xu JF.

BMC Infect Dis. 2015 Mar 27;15:160. doi: 10.1186/s12879-015-0872-5.

7.

Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency.

Cuellar-Rodriguez J, Freeman AF, Grossman J, Su H, Parta M, Murdock H, Shah N, Bollard C, Kong HH, Moutsopoulos N, Stone K, Gea-Banacloche J, Holland SM, Hickstein DD.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1037-45. doi: 10.1016/j.bbmt.2015.01.022. Epub 2015 Jan 27.

8.

Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasis.

Liu J, Zhong X, He Z, Wei L, Zheng X, Zhang J, Bai J, Zhong W, Zhong D.

Mediators Inflamm. 2014;2014:708608. doi: 10.1155/2014/708608. Epub 2014 Nov 4.

9.

Follicular bronchiolitis in primary ciliary dyskinesia.

Thalanayar PM, Holguin F.

Australas Med J. 2014 Jul 31;7(7):294-7. doi: 10.4066/AMJ.2014.2102. eCollection 2014.

10.

Advantages and drawbacks of long-term macrolide use in the treatment of non-cystic fibrosis bronchiectasis.

Fan LC, Xu JF.

J Thorac Dis. 2014 Jul;6(7):867-71. doi: 10.3978/j.issn.2072-1439.2014.07.24.

11.

Macrolide antibiotics and the risk of cardiac arrhythmias.

Albert RK, Schuller JL; COPD Clinical Research Network.

Am J Respir Crit Care Med. 2014 May 15;189(10):1173-80. doi: 10.1164/rccm.201402-0385CI. Review.

12.

Inhaled antibiotics for lower airway infections.

Quon BS, Goss CH, Ramsey BW.

Ann Am Thorac Soc. 2014 Mar;11(3):425-34. doi: 10.1513/AnnalsATS.201311-395FR. Review.

13.

Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.

Gao YH, Guan WJ, Xu G, Tang Y, Gao Y, Lin ZY, Lin ZM, Zhong NS, Chen RC.

PLoS One. 2014 Mar 6;9(3):e90047. doi: 10.1371/journal.pone.0090047. eCollection 2014. Review.

14.

Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.

Wallace RJ Jr, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, York DS, Shepherd S, Griffith DE.

Chest. 2014 Aug;146(2):276-282. doi: 10.1378/chest.13-2538.

15.

Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.

Chang AB, Grimwood K, Wilson AC, van Asperen PP, Byrnes CA, O'Grady KA, Sloots TP, Robertson CF, Torzillo PJ, McCallum GB, Masters IB, Buntain HM, Mackay IM, Ungerer J, Tuppin J, Morris PS.

Trials. 2013 Feb 20;14:53. doi: 10.1186/1745-6215-14-53.

16.

Macrolide therapy in chronic inflammatory diseases.

Asano K, Tryka E, Cho JS, Keicho N.

Mediators Inflamm. 2012;2012:692352. doi: 10.1155/2012/692352. Epub 2012 Dec 30. No abstract available.

17.

Successful treatment of Mycobacterium massiliense lung disease with oral antibiotics only.

Koh WJ, Jeon K, Shin SJ.

Antimicrob Agents Chemother. 2013 Feb;57(2):1098-100. doi: 10.1128/AAC.02016-12. Epub 2012 Nov 26. No abstract available.

18.

Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.

Chang AB, Grimwood K, Robertson CF, Wilson AC, van Asperen PP, O'Grady KA, Sloots TP, Torzillo PJ, Bailey EJ, McCallum GB, Masters IB, Byrnes CA, Chatfield MD, Buntain HM, Mackay IM, Morris PS.

Trials. 2012 Aug 31;13:156. doi: 10.1186/1745-6215-13-156.

19.

Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.

Valery PC, Morris PS, Grimwood K, Torzillo PJ, Byrnes CA, Masters IB, Bauert PA, McCallum GB, Mobberly C, Chang AB.

BMC Pediatr. 2012 Aug 14;12:122.

20.

Ejaculate in differential diagnosis.

Rott HD.

Dtsch Arztebl Int. 2012 Apr;109(17):315; author reply 315. doi: 10.3238/arztebl.2012.0315a. Epub 2012 Apr 27. No abstract available.

Supplemental Content

Loading ...
Support Center